|
Newsfile Corp Toronto, Ontario--(Newsfile Corp. - December 13, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that it has secured rights to distribute the new 1POTT Professional Device (the "1POT") and 1copyT COVID-19 MDx Kit Professional (the "MDx Kit"). Both the 1POT and MDx Kit provide together an accurate result eight times faster than a conventional RT-PCR test through the 1POT Professional app (the "App"). They open doors to rapid and convenient COVID-19 testing in places such as hospitals, clinics, and schools where healthcare professionals are present.  Figure 1: 1POTT Professional Device
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/1778/107213_e73a7abb44ab688b_002full.jpg  Figure 2: 1copyT COVID-19 MDx Kit Professional procedure.
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/1778/107213_e73a7abb44ab688b_003full.jpg "The company is pleased with this new state-of-the-art testing system, opening the door to new revenue streams. A regular lab based PCR test can be substituted with the MDx kit," said Andrew Ryu, Chairman of the Company. "With the new mutations of the virus popping up around the world including the highly contagious Omicron (B.1.1.529) variant, management feels that constant COVID-19 testing will be essential for the immediate future as part of the response to keep people secure and healthy. It is now time to join with Datametrex and the MDx Kit to expand COVID-19 testing for your neighbourhood and effectively prevent the further spread of the global pandemic," said Marshall Gunter, Chief Executive Officer of the Company. The MDx Kit has CE marking certification ("CE") for European Economic Area ("EEA") countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom. |